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Abstract
Human malaria parasites proliferate in different erythroid cell types during infection. Whilst
Plasmodium vivax exhibits a strong preference for immature reticulocytes, the more patho-
genic P. falciparum primarily infects mature erythrocytes. In order to assess if these two cell
types offer different growth conditions and relate them to parasite preference, we compared
the metabolomes of human and rodent reticulocytes with those of their mature erythrocyte
counterparts. Reticulocytes were found to have a more complex, enriched metabolic profile
than mature erythrocytes and a higher level of metabolic overlap between reticulocyte resi-
dent parasite stages and their host cell. This redundancy was assessed by generating a
panel of mutants of the rodent malaria parasite P. berghei with defects in intermediary car-
bon metabolism (ICM) and pyrimidine biosynthesis known to be important for P. falciparum
growth and survival in vitro in mature erythrocytes. P. berghei ICM mutants (pbpepc-, phos-
phoenolpyruvate carboxylase and pbmdh-, malate dehydrogenase) multiplied in reticulo-
cytes and committed to sexual development like wild type parasites. However, P. berghei
pyrimidine biosynthesis mutants (pboprt-, orotate phosphoribosyltransferase and
pbompdc-, orotidine 50-monophosphate decarboxylase) were restricted to growth in the
youngest forms of reticulocytes and had a severe slow growth phenotype in part resulting
from reduced merozoite production. The pbpepc-, pboprt- and pbompdc-mutants retained
virulence in mice implying that malaria parasites can partially salvage pyrimidines but failed
to complete differentiation to various stages in mosquitoes. These findings suggest that
species-specific differences in Plasmodium host cell tropism result in marked differences in
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the necessity for parasite intrinsic metabolism. These data have implications for drug design
when targeting mature erythrocyte or reticulocyte resident parasites.
Author Summary
Malaria, caused by the Apicomplexan parasites Plasmodium spp., is a deadly disease
which poses a huge health and economic burden over many populations in the world,
mostly in sub-Saharan Africa and Asia. To design new intervention strategies and to im-
prove upon existing drugs against malaria, it is useful to understand the biochemistry of
the Plasmodium parasite and its metabolic interplay with the host. Some species of Plas-
modium such as P. vivax grow exclusively in reticulocytes (immature erythrocytes) where-
as others e.g. P. falciparum will also readily multiply in mature erythrocytes. We asked the
questions, do these two classes of host cell offer different resources for parasite survival
and could these resources influence antimalarial drug efficacy? We used metabolomics to
compare rodent reticulocytes and mature erythrocytes and identified that the metabolome
of the former is more diverse and enriched. Gene disruption in the reticulocyte preferring
rodent malaria parasite P. berghei was used to demonstrate that Plasmodium can utilise
the elements of the metabolic reserves of reticulocytes that mature erythrocytes cannot
provide. Our data suggests that the availability of the reticulocyte metabolome might re-
duce or block the efficacy of antimalarial drugs that target parasite metabolism and drugs
tested against P. falciparummight have significantly reduced activity against P. vivax.
Introduction
The malaria-causing apicomplexan parasites Plasmodium spp. have a dynamic life cycle which
is reflected in stage-specific morphologies, transcriptomes, proteomes and metabolomes [1–8].
These changes, particularly in their metabolome, reflect the nutritional needs and biological
processes of the parasite during intracellular development that in turn influences, or is influ-
enced by, the physiological state of the host cell [6]. Perhaps due to their parasitic life-style,
Plasmodium spp. have a simplified and reduced metabolic capacity when compared to higher
non-parasitic organisms. They are auxotrophic for purines, vitamins and many amino acids
[9,10], but have retained core pathways of carbon metabolism such as glycolysis [11], the citric
acid cycle [7,12], lipid synthesis [13,14], the pentose phosphate pathway [15], pyrimidine bio-
synthesis [16] and glycosylation [17]. Plasmodium spp. are obligate intracellular parasites and
their metabolism is interlinked with that of their host cell and is heavily dependent on the avail-
ability of external nutrients. As a result, intracellular Plasmodium establish systems such as the
new permeation pathways with the purpose of accessing host cell and environmental nutrients
[18]; in fact the parasite genome encodes>120 predicted membrane transport proteins, a sub-
set of which are located on the plasma membrane [19].
Erythrocyte invasion is a prerequisite for establishment of infection by Plasmodiummero-
zoites and the roles of different merozoite and host surface proteins in this invasion process
have been intensively studied [20–25]. Multiple partially overlapping erythrocyte invasion
pathways have been described in P. falciparum with consequent functional redundancy [26].
Many Plasmodium spp. including P. falciparum preferentially invade reticulocytes [27] which
is also capable of invading and replicating within all stages of erythrocyte development includ-
ing mature cells. However, P. vivax has a strict requirement for growth in reticulocytes,
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expresses reticulocyte binding proteins [28] and requires a host Duffy blood group glycopro-
tein for invasion [29]. P. vivax infection causes accelerated remodelling of very young reticulo-
cytes, a process that normally takes 24 hours in uninfected reticulocytes [30]. The rodent
model malaria parasite, P. berghei is also 150 times more likely to invade reticulocytes and es-
tablish infection in the presence of equal numbers of mature erythrocytes and reticulocytes
[31] and has therefore been long thought of as a suitable model for P. vivax blood stage biology
[32].
Mature erythrocytes, comprising almost 98% of the circulating red blood cells, can be con-
sidered “simplified” cells; they are metabolically active but lack intracellular organelles found
in the bone marrow erythroid precursors cells [33] and enucleated reticulocytes (maturing
erythrocytes) that are present in peripheral circulation [34]. Reticulocytes undergo many
changes after their release into the peripheral circulation as they mature and this is associated
with a 20% decrease in total surface area and acquisition of a biconcave shape with consequent
increase in shear membrane resistance, the progressive loss of organelles (mitochondria, ribo-
somes and lysosomes), the loss or reduced abundance of up to 30 membrane proteins, and de-
creased levels of membrane cholesterol [34,35]. This maturation process is associated with a
general streamlining of cellular metabolism; mature erythrocytes are highly dependent on gly-
colysis [36] and the pentose phosphate pathway [37] for both energy and redox balance and
lack many other pathways of carbon metabolism, such as citric acid cycle [38]. Reticulocytes
are thus expected to contain a richer repertoire of carbon sources and other essential nutrients
than mature erythrocytes which might be exploited or even required by reticulocyte preferent
Plasmodium spp.
Limited comparative metabolomics of the erythroid lineage has been attempted before but
focussed on sickle cell disease and cord blood reticulocyte physiology [39,40]. Therefore, in
order to establish whether there are metabolic differences between reticulocytes and mature
erythrocytes that could influence the tropism of different Plasmodium spp., we undertook a
non-targeted, high coverage, comprehensive analysis of the metabolomes of these host cells.
Comparison of the metabolomes of very young, uninfected rat and human reticulocytes and
their mature erythrocyte counterparts revealed major biochemical differences that could be ex-
ploited by intracellular parasite stages. This was tested using reverse genetics to disrupt parasite
metabolism and establish the broad ability of P. berghei to utilise the products of reticulocyte
metabolism and (in part) explain differing profiles of drug susceptibility between parasites in
mature erythrocyte and reticulocyte environments.
Results
The reticulocyte metabolome is more complex than that of the mature
erythrocyte
Induction of reticulocytosis was achieved through administration of phenylhydrazine-HCl
(PHZ, 100 mg/kg body weight) to Wistar rats and cells were harvested when the percentage of
reticulocytes in the peripheral blood reached a maximum at day 5 (~35% reticulocytes). This
was monitored by FACS analysis using the reticulocyte surface marker transferrin receptor
(CD71), which is lost as reticulocytes mature[35]. More than 90% of the 35% reticulocyte pop-
ulation generated by PHZ treatment were CD71-high at the time of harvest (Fig A-A in S1
Text) corresponding to the youngest of the four forms of reticulocytes that have been identified
[39] and are from here on referred to as Reticulocyte enriched Erythrocyte Population (REP)
Material was also collected for comparison with blood from non-enriched (~1% reticulocytes)
animals- wild type Erythrocyte Population (wtEP) (Fig 1A). All samples were uniformly de-
pleted of leucocytes.
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Fig 1. Comparison of Reticulocyte enriched Erythrocyte Population (REP) and wild type Erythrocyte Population (wtEP) reveals metabolite
enrichment in rodent and human reticulocytes. A. Dynamics of reticulocyte enrichment in peripheral blood in vivo followed by Phenylhydrazine-HCl (phz)
treatment of mice. Reticulocytes were harvested at day 5 post phz treatment. The error is given as the standard deviation (S.D.) of 3 independent biological
replicates. B. Volcano plot showing distribution of putative metabolites according to their fold change in abundance in REP vs wtEP in rodent blood. All
significant changes are represented above the broken horizontal line. Coloured dots indicate metabolites which are: Blue- significantly up-regulated, Red-
significantly down-regulated, Yellow- significant but little change, Brown- non-significant. n = 3 independent biological replicates (with four internal technical
replicates each). Significance tested byWelch’s T-test (α < 0.05). See Fig A-C in S1 Text and S1 Table in for the complete list of detected metabolites and
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Metabolite extracts of REP and wtEP were analysed in parallel by liquid chromatography
mass spectrometry (LC-MS) and gas chromatography mass spectrometry (GC-MS), providing
overlapping, as well as complementary coverage of the metabolomes of wtEP and REP. LC-MS
data was processed using XCMS, MZMatch and IDEOMwhile GC-MS data was processed
using PyMSmatrix generation and Chemstation Electron Ionisation (EI) spectrummatch analy-
sis (described in detail in methods). A total of 333 metabolites were provisionally identified from
a total of 4,560 mass features and peaks. The volcano plot in Fig 1B shows the distribution of
abundance of detected metabolites in REP compared to wtEP. Almost half of all detected metab-
olites (147, ~45%) were found to be more than 2-fold more abundant in REP (with a p<0.05)
(Fig 1B and A-C in S1 Text and S1 Table). Only 5 (~1%) metabolites were over 2-fold more
abundant in wtEP than in REP (with p<0.05). The rest of the metabolites did not show a signifi-
cant difference between REP and wtEP. Similar changes were observed when all mass features
and peaks (~4,560 peaks) were included in the analyses. Specifically, of the ~4,230 unassigned
mass features/peaks, 1,051 (~23%) were up-regulated and 91 peaks (~2%) down regulated in
REP (Fig A-B in S1 Text). As the blood from reticulocytosis-induced rats still contained a major
fraction of mature erythrocytes (1:2 final ratio of reticulocytes to mature erythrocytes) the level
of metabolite enrichment in reticulocytes was actually much greater (column four, S1 Table). 20
representative metabolites up-regulated in rodent REP showed a similar ‘trend’ towards up-regu-
lation in very young human reticulocytes grown in vitro from CD34+ stem cells [41] analysed
using LC-MS (Fig 1C), except carnitine derivatives. All identified metabolites were charted on
metabolic pathways known to exist in Plasmodium and mammalian host cell from biochemical
studies [6,7,12,42,43] and genomic data [44], although it is expected that not all detected metabo-
lites are endogenously synthesised, as plasma metabolites from other tissues, the microbiome,
the diet and environment may also accumulate in erythrocytes.
The reticulocyte metabolome reflects its ongoing developmental
programme
Cell fractions from rodent REP contained elevated levels of glycolytic, pentose phosphate path-
way and TCA cycle intermediates (S1 Table). The presence of the latter indicates that reticulo-
cytes have a functional TCA cycle and associated intermediary carbon metabolism, consistent
with the presence of a residual population of mitochondria in reticulocytes that are largely lost
in mature erythrocytes [34]. Increases in the levels of intermediates of the purine and pyrimi-
dine metabolic pathways in reticulocytes presumably originate either from biosynthesis in the
preceding erythropoiesis stages or from catabolism of nucleic acid to their constituent nucleo-
bases [45]. A number of intermediates of phospholipid metabolism were also elevated in reticu-
locytes compared to mature erythrocytes. Other notable changes included elevated levels of
intermediates in glutathione and arginine metabolism in reticulocytes (S1 Table). In addition,
many carnitine derivatives were found to be up-regulated in rodent (although interestingly not
in human) reticulocytes which may relate to fatty acid catabolism by β-oxidation in the mito-
chondria or peroxisomes of these cells. Although decreased levels of carnitines have previously
been found in human erythrocytes derived from normal subjects compared to individuals with
Sickle-Cell (HbSS) disease [40], the procedures used for production of rodent reticulocytes (in
vivo) and human reticulocytes (in vitro) cannot be ruled out as the reason for this difference
their respective abundance fold changes. C. Representative metabolites up-regulated in reticulocytes compared to mature erythrocytes in human and rodent
erythrocytes. Relative levels (peak intensities) are expressed as fold change observed in reticulocyte vs mature erythrocytes. Dotted line indicates no change
and error bars indicate R.S.D. (Relative Standard Deviation) of peak intensities from reticulocyte samples multiplied to the fold change values from n = 3
independent biological replicates.
doi:10.1371/journal.ppat.1004882.g001
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observed between the two species as carnitine is produced in mammalian tissues (skeletal mus-
cle, heart, liver, kidney, and brain) [46] a contributory factor missing in in vitro conditions. Al-
most 65% of the other metabolite ions detected in the HbSS study were also found to be
present in erythrocytes in our analysis (S1 Table) and around 17% of metabolites detected in
our analysis were also reported in erythrocytes in that study [40]. This difference in coverage
could be due to the chromatographic and detection methods which differ between the analyses.
Taken together these data demonstrate that the reticulocyte contains elevated levels of
many metabolites that could potentially be scavenged by the invading malaria parasite. Fur-
thermore, there was a marked overlap in metabolic pathways observed in the reticulocyte and
those predicted in the parasite [43,44]. Common pathways might therefore be uniquely dis-
pensable to Plasmodium during its growth in the reticulocyte compared with that in mature
erythrocytes. To test this hypothesis, we used reverse genetics to target several metabolic path-
ways in intermediary metabolism and pyrimidine biosynthesis in P. berghei whose intermedi-
ates were significantly up-regulated in reticulocytes.
Features of intermediary carbon metabolism are dispensable in asexual
blood stage P. berghei
Asexual red blood cell stages of Plasmodium spp. catabolize glucose via the intermediary carbon
metabolic pathways depicted in Fig 2A and express the cytosolic enzymes, phosphoenolpyruvate
carboxylase (pepc PBANKA_101790), malate dehydrogenase (mdh PBANKA_111770) and as-
partate amino transferase (aat PBANKA_030230). De novo synthesis of aspartate is likely to be
important for nucleic acid synthesis as this amino acid is utilised in both purine salvage and as a
carbon skeleton in pyrimidine biosynthesis [47] and inhibition of aat has been shown to be lethal
to P. falciparum [48]. Malate produced by these pathways either enters mitochondria to partici-
pate in the TCA cycle or is excreted [7,42].
Metabolites involved in TCA cycle and intermediary carbon metabolism (ICM), including
malate and aspartate, were found to be substantially higher in REP compared to wtEP (Fig 2A).
The elevated levels of these intermediates may possibly explain the previous observation that
disruption of the TCA cycle in P. berghei blood stages through deletion of flavoprotein (Fp)
subunit of the succinate dehydrogenase, pbsdha (PBANKA_051820), had little effect on para-
site viability in blood stage forms, although ookinete development was impaired [49]. To fur-
ther explore the possibility that P. berghei has potential access to the anapleurotic substrates of
reticulocyte ICM, attempts were made to delete pepc,mdh and aat in P. berghei and assess the
importance of these parasite enzymes throughout the life cycle (Fig 2A). P. bergheimutants
lacking both pepc andmdh were generated (Fig B in S1 Text), while deletion of aat proved re-
fractory. Both the pepc- andmdh- mutant parasites caused severe cerebral malaria in CD57/B6
mouse model with similar dynamics to wt parasites (Fig 3B). Interestingly, the growth of the
pepc- mutant was compromised compared to wild type parasites, as the pepc- mutant, but not
themdh- mutant was overgrown by the wt parasite in an in vivo sensitive single host competi-
tive growth assay (Fig 3A and C-A in S1 Text). The number of merozoites observed in mature
schizont stages in both pepc- (17.02 ± 1.8) andmdh- (17.41 ± 1.7) mutants are similar to wt
(17.4±1.8) (Fig C-C in S1 Text). Scrutiny of the growth phenotype detected in the pepc- mu-
tants showed that they have a prolonged asexual cycle (4 h longer than wt) (p<0.05) (Fig C-B
in S1 Text). The number of gametocytes formed in blood stages was also reduced in pepc- mu-
tants by almost 50% but unaffected inmdh- (p>0.05) (Fig 3C) with no notable difference in
male to female ratio in either mutant. Further phenotypic analyses showed reduction of exfla-
gellation (pepc- mutants 84% less than wt, p<0.0005;mdh- mutants 56% less than wt, p<0.005)
(Fig 3D). DNA replication in male gametocytes as observed by FACS analysis was reduced by
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50% compared to wt at the 8 minute time point and further delayed taking up to 16 minutes to
complete (Fig C-E and C-D in S1 Text). Ookinete development in in vitro cultures of pepc- mu-
tants was also severely affected while inmdh- mutants, ookinetes were formed but the number
was reduced by about 50% compared to wt (Fig 4A). To determine if this defect was sex specif-
ic, crosses of pepc- andmdh- were performed with P. berghei lines RMgm-348 (Pb270, p47-)
which produces viable male gametes but non-viable female gametes and RMgm-15 (Pb137,
p48/45-) which produces viable female gametes but non-viable male gametes [50]. Mutants of
pepc- were found to produce severely reduced numbers of ookinetes in either cross suggesting
that gametes of both genders are affected and that the activity of the protein is essential for via-
ble gamete formation. This was not the case formdh- mutants where although crossing experi-
ments showed that lack of MDH protein affected both genders, they mimicked the parental
phenotype producing 50% fewer mature ookinetes (Fig 4B). The pepc- parasites were defective
in development within the mosquitoes, forming small numbers of oocysts in mosquito midguts
and no salivary gland sporozoites. However, parasites lackingmdh could complete transmis-
sion through the mosquito and infect mice generating blood stage asexual forms in 48–72
hours similar to wt despite producing reduced numbers of oocysts when compared to wt (Fig
4C and 4D and D-A and D-B in S1 Text). Overall, these results suggest that two key enzymes
in P. berghei ICM are at least partially redundant during stages of infection in which the para-
sites resides primarily in reticulocytes, but that they become essential as parasite differentiates
and proliferates within other host or vector cell types.
Pyrimidine biosynthesis can be partially disrupted in reticulocyte-
preferent P. berghei
Plasmodium spp. are heavily dependent on nucleic acid synthesis during blood stage asexual
growth and either salvage (i.e. purines) or synthesize (i.e. pyrimidines) the requisite bases. A
schematic representation of the pyrimidine biosynthesis pathway is given in Fig 2B. Five out of
six enzymes of this pathway have been shown to be essential for P. falciparum growth in stan-
dard in vitro cultures, based on pharmacological studies [51]. Interestingly, most of these inhibi-
tors are markedly less potent in the in vivo P. bergheimodel, a feature that has been attributed to
reduced bio-availability of inhibitors in mice or apparent differences in target enzyme structures
[52,53]. However, increased resistance to pyrimidine biosynthetic inhibitors could also reflect
higher concentrations of pyrimidine precursors (bar glutamine) in the reticulocyte population
selectively colonized by this species (Fig 2B) [16,51]. To investigate this possibility we attempted
to delete in P. berghei 6 genes encoding enzymes involved in pyrimidine biosynthesis; carbamoyl
phosphate synthetase II (cpsII) (PBANKA_140670), aspartate carbamoyltransferase (act)
(PBANKA_135770), dihydroorotase (dhoase) (PBANKA_133610), dihydroorotate dehydroge-
nase (dhodh) (PBANKA_010210), orotate phosphoribosyltransferase (oprt) (PBANKA_111240)
Fig 2. Metabolites of intermediary carbonmetabolism (ICM) and pyrimidine biosynthesis are up-regulated in reticulocytes. A. Top panel: Fold
change of relative levels (peak intensities) of metabolites of carbon metabolism in rodent REP compared to wtEP. Dotted line indicates no change and error
bars indicate R.S.D. (Relative Standard Deviation) of peak intensities from reticulocyte samples multiplied to the fold change values from n = 3 independent
biological replicates. Bottom panel: Schematic representation of intermediary carbon metabolism (ICM) in Plasmodium cytosol. Genes marked with (✓) were
deleted in P. berghei blood stages and the ones marked with (✕) could not be deleted even after repeated attempts. pepc: Phosphoenolpyruvate
Carboxylase (PBANKA_101790),mdh: Malate Dehydrogenase (PBANKA_111770), aat: Aspartate Amino Transferase (PBANKA_030230). B. Top panel:
Fold change of relative levels (peak intensities) of metabolites of pyrimidine biosynthesis in rodent REP compared to wtEP. Dotted line indicates no change
and error bars indicate R.S.D. (Relative Standard Deviation) of peak intensities from reticulocyte samples multiplied to the fold change values from n = 3
independent biological replicates. Bottom panel: Schematic representation of pyrimidine biosynthesis pathway in Plasmodium cytosol. Genes marked with
(✓) were deleted in P. berghei blood stages and the ones marked with (✕) could not be deleted even after repeated attempts. cpsII: Carbamoyl phosphate
synthetase II (PBANKA_140670), act: Aspartate carbamoyltransferase (PBANKA_135770), dhoase: Dihydroorotase (PBANKA_133610), dhodh:
Dihydroorotate dehydrogenase (PBANKA_010210), oprt: Orotate phosphoribosyltransferase (PBANKA_111240), ompdc: Orotidine 50-monophosphate
decarboxylase (PBANKA_050740). (Also see Fig B in S1 Text for gene deletion strategy and confirmation)
doi:10.1371/journal.ppat.1004882.g002
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Fig 3. Phenotypic analyses of blood stagemutant P. berghei parasites. A. in vivo growth assay of mutants in mixed infections in competition with wild
type parasites over 12 days. Coloured lines represent non-linear fit of percentage of mutant parasites in total parasite population. Data representative of n = 3
independent biological replicates. (Also see Fig C- A, B and C in S1 Text.) B. Lethality experiment in C57/B6 mice by wt and mutant P. berghei parasites. 104
parasites were injected intra-peritoneally in mice (n = 5) on day 0 and they were monitored for 21 days. The mice were culled humanely when they showed
severe malaria pathology. All mutant parasites were found to be lethal to mice. C. Gametocyte conversions during blood stages in mutant P. berghei
parasites over 5 days post infection. Data from 2 independent observed gametocyte conversion experiments are shown ± S.D. Gametocyte conversion was
observed using a wt parent line which expresses GFP in male gametocytes and RFP in female gametocytes (RMgm-164). P. bergheimutants were
generated in the same genetic background and analysed using FACS determining the number of gametocytes in infected blood. P-values: *p<0.05,
**p<0.005, ***p<0.0005, paired two tailed t-test. D. Exflagellation (male gamete formation) in mutant P. berghei parasites normalised to wt in in vitro
activation assay. The error is given as the SD of n = 3 independent biological replicates. P-values: **p<0.005, ***p<0.0005, paired two tailed t-test.
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and orotidine 50-monophosphate decarboxylase (ompdc) (PBANKA_050740). While the first
four enzymes in this pathway were refractory to deletion, the last two enzymes in pyrimidine
biosynthesis, orotate phosphoribosyltransferase (oprt) and orotidine 50-monophosphate decar-
boxylase (ompdc) could be deleted (Fig B in S1 Text). The oprt- and ompdc-mutant parasites
grew slowly (asexual cycle prolonged by approximately 4–5 hours compared to wt (p<0.05)),
were rapidly outgrown in a competition growth assay with wt parasites (Fig 3A) and based on
gray value-1 of staining intensity as observed by Giemsa staining (p<0.0005), seem to invade
very young reticulocytes (Fig C-E in S1 Text). However, these infected reticulocytes could not be
classified as CD71-high possibly due to the accelerated loss of the CD71 as observed with P.
vivax infected reticulocytes [30]. Furthermore, both oprt-mutants (15.9 ± 2.0, p<0.0005) and
ompdc-mutants (15.2 ± 2.5, p<0.0005) were found to generate, on average, significantly fewer
merozoites than wt parasites (17.5 ± 1.8) per schizont (counted after completion of asexual
cycle) (Fig C-C in S1 Text) and the asexual parasites also took longer to mature to schizonts (Fig
C-B in S1 Text). Both mutants showed altered lethality in the C57/B6 mouse model as the mice
infected with the mutants did not manifest the symptoms of experimental cerebral malaria
(ECM) but died between days 14–20 as a result of severe anaemia and hyperparasitemia (Fig
3B). The process of transmission was also affected by the loss of ompdc and oprt. Gametocytemia
was significantly reduced only in oprt- parasites (Fig 3C) but no change was seen in male- female
ratio. Exflagellation (the production of mature male gametes) was found to be severely affected
in oprt- and completely blocked in ompdc- parasites (Fig 3D) and DNA replication during male
gametogenesis was severely reduced (Fig 3E). Consistent with the defects in male gametogenesis,
very few ookinetes were formed in in vitro cultures in oprt- parasites and no ookinetes were ob-
served in ompdc- (Fig 4A). Genetic crosses of oprt- and ompdc- mutants were performed as above
with P. berghei lines RMgm-348 and RMgm-15 which showed that viable male gametes (from
RMgm-348) were able to rescue the ookinete conversion defect in both mutant lines suggesting
that formation of male gametes is impaired in both oprt- and ompdc- mutant parasites while fe-
male gametes remain unaffected (Fig 4B). Infectivity to the mosquito was significantly reduced
in oprt- and completely blocked in ompdc-mutants as seen by observing oocysts in infected mos-
quito midguts and salivary gland sporozoites (Fig 4C and 4D and D-C and D-D in S1 Text) and
infection to naïve mice was found to be completely blocked. However, when ookinetes from p47-
x oprt- or ompdc- crosses were fed to mosquitoes, they failed to develop into mature oocysts (Fig
E in S1 Text) hence, did not complete sporogony indicating that lack of both oprt and ompdc in
the female lineage results in an allelic insufficiency in a growing oocyst.
We also tested the effect of a previously published inhibitor of pyrimidine biosynthesis
5-fluoroorotate (5FOA) [54] on asexual growth of both P. falciparum and P. berghei. The com-
parisons were carried out in vitro to prevent bioavailability of the inhibitor confounding in vivo
data in mice. We tested the activity and found that the IC50 value of 5FOA in vitro was almost
90-fold higher in P. berghei (32.2 ± 0.9 nM) compared to P. falciparum (0.37 ± 0.01 nM) (Fig 5).
A dihydroartemisinin control showed no major difference in inhibition between P. berghei
(6.6 ± 0.1 nM) and P. falciparum (2.8 ± 0.2 nM). These data strongly suggest that P. berghei can
access pyrimidine precursors from the reticulocyte and are consistent with a role of host cell me-
tabolism in the differential activity of 5FOA, although differences in sensitivity of P. falciparum
E. Determination of DNA content of male gametocytes over 20 minutes post activation by FACS analysis in mutant P. berghei parasites normalised to wt.
DNA content was determined in Hoechst-33258-stained MACS purified gametocytes. Before activation (0minutes) males show low DNA content with
increasing amounts post activation reaching maximum levels between 8 to 12 minutes in wt. Data from 3 independent biological replicates are given ± S.D.
P-values: **p<0.005, ***p<0.0005, unpaired two tailed t-test (also see Fig C- D in S1 Text).
doi:10.1371/journal.ppat.1004882.g003
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Fig 4. Mosquito stage development of P. bergheimutant parasites (also see Fig D in S1 Text). A. in vitro ookinete conversion of mutant P. berghei
parasites as compared to wt. The error is given as the S.D. of n = 3 independent biological replicates. P-values: **p<0.005, ***p<0.0005, unpaired two tailed
t-test. B. in vitro ookinete conversion assay to measure fertility of mutant P. berghei gametocytes. Fertility of mutant P. berghei gametocytes was analysed by
their capacity to form ookinetes by crossing gametes with RMgm-348 (Pb270, p47-) which produces viable male gametes but non-viable female gametes and
RMgm-15 (Pb137, p48/45-) which produces viable female gametes but non-viable male gametes. The error is given as the S.D. of n = 2 independent
biological replicates. P-values: *p<0.05, **p<0.005, unpaired two tailed t-test. C. Number of mature oocysts at day 14 post infected blood feed in mosquito
mid guts. n = 40 mosquitoes cumulative of two independent biological replicates. ***p<0.0005, unpaired two tailed t-test. D. Infection prevalence
(percentage of observed mosquitoes found to be infected) and infection load (median of number of oocysts found per mosquito) in mutant P.berghei
parasites compared to wt.
doi:10.1371/journal.ppat.1004882.g004
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[55] and P. berghei [56] thymidylate synthase or differences in drug uptake could also contribute
to the differential lethality.
Discussion
These metabolomics analyses clearly showed that reticulocytes have a much more complex
metabolome than mature erythrocytes, adding to previously well documented changes that
occur in both organelle complement and protein expression levels during reticulocyte matura-
tion in peripheral circulation [34,35]. Key metabolic processes that were found to be elevated
in REP but absent or highly reduced in wtEP included the TCA cycle and associated intermedi-
ary carbon metabolism, nucleic acid metabolism, phospholipid metabolism, fatty acid catabo-
lism and glutathione metabolism. The down-regulation of these host pathways in wtEP may
explain why several of the corresponding pathways in asexual blood stages of P. falciparum ap-
pear to be essential in vitro. Conversely, we predicted that malaria parasites infectious to both
humans (P. vivax) and rodents (P. berghei) which exhibit a strong tropism for reticulocytes
rather than mature erythrocytes may be more tolerant to loss of key metabolic pathways be-
cause of redundancy with host pathways. Our data strongly suggest that reticulocytes do indeed
provide a highly enriched host cell niche for Plasmodium, with important implications for
drug discovery strategies. Although the reticulocyte offers a very different nutrient resource
compared to the mature erythrocyte, there has been apparently little change in the metabolic
capacity of P. vivax and P. berghei. Our in silico comparison (S3 Table) reveals that P. vivax
and P. berghei have 98% and 97% orthology, respectively, to P. falciparum genes annotated
with metabolic pathway information (434 genes) on PlasmoDB.
Fig 5. P. berghei and P. falciparum inhibition by dihydroartemisinin (DHA) and 5-fluoroorotic acid (5FOA) in vitro. Error bars indicate S.D. from n = 3
biological replicates.
doi:10.1371/journal.ppat.1004882.g005
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The enriched reticulocyte metabolome supports growth of metabolically
compromised P. berghei
Although a small number of metabolomics studies have been undertaken on erythrocytes, in-
cluding a comparison of normal and HbSS erythrocytes, the number and range of metabolites
detected in these studies were relatively small (20–90) [39,40]. Here we used complementary
LC-MS and GS-MS analytical platforms to maximise coverage, generating the most compre-
hensive coverage of REP and wtEP undertaken to date (333 metabolites). These studies re-
vealed a much higher degree of metabolic complexity in reticulocytes compared to mature
erythrocytes covering nearly all major pathways in central carbon metabolism. Whilst glycoly-
sis is the main pathway for carbon metabolism in erythrocytes [36], both human [57] and ro-
dent [58] erythrocytes retain a residual proteomic signature of TCA cycle and ICM enzymes
and our metabolomics data suggests that these pathways are much more active in reticulocytes,
leading to elevated levels of TCA intermediates (including citrate, malate) and ICM products
(e.g. aspartate). The functional significance of increased metabolic complexity in reticulocytes
was subsequently tested by generating P. bergheimutants with specific defects in metabolism
showing that the increased availability of complementary metabolites in reticulocytes can ex-
plain the non-essential nature of the P. berghei pepc andmdh genes, which are involved in regu-
lating intracellular levels of oxaloacetate and malate. In contrast, PEPC is essential for normal
intra-erythrocytic survival of P. falciparum in vitro, although this can be bypassed by malate
supplementation of P. falciparum infected mature erythrocytes [42]. It should be noted that
whilst the P. berghei pepc- mutant retained its virulence, it still showed a significant growth de-
fect compared with wild type parasites (similar to the P. falciparummutant [42]) resulting at
least in part from a prolongation of the asexual blood stage cycle as revealed by our sensitive
single host competitive growth assay. It would be interesting to use this assay to compare asex-
ual growth dynamics of other available metabolic mutants such as the pbsdha- with wild type
which might reveal additional defects to those reported [49]. The P. berghei pepc- mutant also
failed to complete transmission through mosquitoes as a result of defects in gametocyte pro-
duction, male gamete formation, female gamete viability resulting in trace oocyst formation
and failure to enter sporogony, which extends our understanding of the importance of this
metabolic enzyme for parasite development beyond the asexual blood stages previously investi-
gated [42]. A possible explanation for this phenotype is that the pepc- mutant is unable to by-
pass the need for de novo synthesized aspartate for nucleotide biosynthesis by salvage from dif-
ferent host cells during its sexual and asexual life cycle (Fig 2A). The demonstration of pbpepc-
growth in reticulocytes suggests that the equivalent P. falciparummutant might be a suitable
candidate for an attenuated slow growing parasite vaccine that would permit generation of sig-
nificant anti-parasitic immune responses.
In line with this suggestion, we were unable to delete pbaat which is also required for de
novo synthesis of aspartate. The essential nature of pbaat suggests that either the apparently
higher levels of aspartate in reticulocytes are insufficient to meet the demands of a growing
asexual stage parasite or that, as in P. falciparum intra-erythrocytic stages, P. berghei is not
readily able to access host cytoplasmic pools of aspartate [59]. Production of aspartate in Plas-
modium pepc- mutants can still be achieved through generation of the oxaloacetic acid precur-
sor by mitochondrial malate: quinone oxidoreductase (MQO) or the reverse reaction of
cytosolic MDH. However, this is apparently a suboptimal solution for the pepc- parasite result-
ing in slow growth in the blood stage and failure to develop in the mosquito. Plasmodium AAT
can also generate methionine from aspartate, glutamate and other amino acids which can act
as effective amino group donors [60] and regulate glutamine/glutamate metabolism. These
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functions may not be rescued by simple aspartate salvage from the host and further support
the essentiality of aat as a key enzyme for the parasite and a possible drug target.
The P. falciparum gene encoding MDH has proved refractory to deletion under any circum-
stances so far, suggesting that it is essential for these parasites. In marked contrast, the P. ber-
gheimutants lacking pbmdh were readily generated, suggesting that this species may scavenge
reticulocyte pools of malate or other intermediates in the TCA cycle. The pbmdhmutant exhib-
ited a very modest growth phenotype and was able to develop into mosquito infective stages, al-
though it produced 30% fewer oocysts than wt parasites. The continued viability of the pbmdh-
mutants during transmission in the absence of reticulocyte-based compensatory sources of the
metabolite can be explained by continued TCA derived production of malate and NADH+ H+
reducing equivalents given the increased flux through the TCA metabolism in gametocytes and
probably later sexual stages [7,12]. Conditional silencing or disruption of pfmdh or degradation
of PfMDH in mature gametocytes or later stages of P. falciparum would establish if MDH is re-
quired for transmission of the human parasite and that the essential nature of this enzyme is
merely blood stage specific.
P. berghei is partially capable of pyrimidine salvage in highly immature
reticulocytes
Plasmodium spp. salvage their purine requirements from the host cell, but retain the ability to
synthesise pyrimidines [61]. Purine nucleosides are taken up by the parasite PfNT1 and other,
as yet, unidentified AMP transporters [62] after they are delivered to the parasitophorous vacu-
ole via the action of erythrocyte nucleoside transporters [51,63] and a non-selective transport
process [61,64]. In contrast, while other Apicomplexans (i.e. Cryptosporidium spp., Toxoplas-
ma spp.) retain the capacity to salvage pyrimidines [16], Plasmodium spp. are thought to lack
enzymes required for host pyrimidine salvage [44]. Although, Plasmodium proteins have been
implicated in transporting some pyrimidine precursors [65,66], presumably due to very limited
availability of pyrimidines in the host cell, Plasmodium parasites have been thought to be
completely dependent on de novo pyrimidine synthesis for growth in asexual stages [51].
The survival of both oprt-and ompdc-mutants could be the result of two possibilities that
are not mutually exclusive. The first possibility is that the mutants directly utilize reticulocyte
pools of pyrimidines which are nonetheless limiting leading to a reduction in number of mero-
zoites produced. Alternatively, mutant parasites could synthesize orotate which is secreted into
the host cytoplasm and converted to UMP by host UMP synthase before being salvaged. Both
outcomes require transport of nucleosides or nucleotides from the host cytoplasm to the para-
site and how this is achieved is not clear. Both pyrimidine biosynthesis mutants survive only in
the youngest reticulocytes which might reflect either adequacy of supply of host UMP (or de-
rivatives) or the capacity of the youngest reticulocytes to convert parasite-derived orotate. In-
deed enzymes involved in the later stages of pyrimidine biosynthesis, nucleoside diphosphate
kinase B, CTP synthase and ribonucleotide reductase large subunit have been identified in ro-
dent and human erythrocytes [57,58]. The possibility that host pyrimidine enzymes may have
redundant functions with the parasite enzymes catalysing late steps in pyrimidine biosynthesis
is supported by the apparent essentiality of the P. berghei genes encoding the first four steps of
pyrimidine biosynthesis. A simplified illustration of life cycle stages of P. berghei development
showing the characteristics of mutant parasites at various points in the life cycle is shown in
Fig G in S1 Text.
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Glutathione biosynthesis is elevated in reticulocytes
The REP metabolome also explains other species-specific differences between P. berghei and P.
falciparum. Glutathione biosynthesis occurs in erythrocytes [67] and the enzymes for this path-
way have been shown to be present in both human [57] and rodent [58] erythrocytes. Plasmo-
dium employs its own glutathione redox system [68] to counter oxidative stress (Fig F-A in S1
Text). Both ɣ-glutamylcysteine synthetase (ɣ-gcs) and glutathione synthetase (gs) are essential
for parasite survival in P. falciparum [69] yet ɣ-gcs and glutathione reductase (gr) can be delet-
ed in P. berghei and intra-erythrocytic asexual growth is unaffected although mosquito stage
development is arrested at the oocyst stage [70,71]. The REP and wtEP metabolomes demon-
strated that the levels of glutathione synthesis intermediates were higher in reticulocytes than
in mature erythrocytes (Fig F-B in S1 Text) providing a mechanistic explanation for the normal
growth of P. berghei ɣ-gcs and grmutant asexual stages in reticulocytes. Also, the inhibitor of
ɣ-gcs, buthionine sulphoximine (BSO) inhibits P. falciparum growth with an IC50 value of
~60 μM [69] yet concentrations as high as 500 μM BSO in vitro had no inhibitory effect on P.
berghei parasites in in vitro cultures (Fig F-C in S1 Text) consistent with the reticulocyte medi-
ated rescue of chemical disruption of the glutathione synthesis pathway in P. berghei, although
it has not been investigated whether there is a difference in BSO sensitivity against the mouse
or P. berghei ɣ-gcs compared to P.falciparum or human enzymes.
Host cell metabolism can ameliorate the impact of different drug
treatments
Enzymes involved in Plasmodium intermediary carbon metabolism [12,42] and pyrimidine
biosynthesis [51] are considered attractive targets for drug development. The metabolome sur-
veys and drug inhibition data presented here suggest that caution should be used before extrap-
olating conclusions regarding gene essentiality in reticulocyte preferent parasites such as P.
berghei as part of any drug discovery pathway that has been based initially upon screens in ma-
ture erythrocytes. Bioavailability in mouse models and/or drug penetration into the reticulo-
cyte and difference in target enzyme structures between species have been proposed as reasons
for the relative ineffectiveness of drugs when tested in vivo using P. berghei [52,53]. An alterna-
tive view is that the reticulocyte metabolome (at least in part) provides a reservoir of metabo-
lites downstream of the point of action of a drug rendering the drug less effective. This has a
number of consequences:
1. Good drug candidates for P. falciparummight be (already have been) eliminated from fur-
ther development due to adverse and misleading data from in vivo P. berghei testing.
2. Alternative mature erythrocyte preferent rodent parasites (e.g. P. yoelii YM) [72] might
provide a more accurate in vivomodel in which to test drug candidates for P. falciparum
malaria.
3. P. berghei could provide an accurate in vivomodel for the development of drugs against re-
ticulocyte preferent parasites such as P. vivax, and this warrants further investigation.
4. Recrudescence of P. falciparum infection during treatment with anti-malarials that target
parasite metabolism (anti-metabolites) might result from their survival in a ‘protective’ re-
ticulocyte niche, the existence of which cannot be predicted by standard in vitro cultures.
5. Reticulocyte resident parasites exposed to anti-metabolites at levels determined by in vitro
culture in mature erythrocytes would be sub-optimal with the subsequent risk of being
more conducive for the selection of drug resistant progeny.
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Materials and Methods
Metabolomics of rodent erythrocytes
Rodent reticulocyte enrichment was done in rats by administering phenylhydrazine-HCl dis-
solved in 0.9% NaCl (w/v) at a dose of 100 mg/kg body weight and collecting reticulocyte en-
riched peripheral blood on day 5 post injection. Metabolite extraction was done as using
chloroform/methanol/water (1:3:1 v/v) and samples were analysed using LC-MS and GC-MS.
See S1 supplementary materials and methods for details.
Metabolomics of human CD34+ stem cell grown erythrocytes
CD34+ cells obtained from blood from human volunteers were cultured in a three-stage proto-
col based on the methods of [41]. Cultured reticulocytes and mature erythrocytes from match-
ing donors were used for metabolite extraction with chloroform/methanol/water (1:3:1 v/v)
and samples were analyzed using LC-MS. See S1 supplementary materials and methods
for details.
P. bergheimethods
Infection of laboratory mice, asexual culture of P. berghei stages and generation of knockout
parasites was done as before [73]. Asexual growth competition assay was done by mixing wt
and mutant parasites expressing different fluorescent markers and injecting them intravenous-
ly into recipient mice and monitoring the growth of the two populations by flow cytometry as
done before [74]. Lethality of mutant P. berghei parasites was checked by injecting infected
RBCs (104) into C57/B6 mice and monitoring parasitaemia, disease pathology and mortality
over 21 days. Gametocyte conversion was monitored by flow cytometry in mutants generated
in parent line (820cl1m1cl1) expressing GFP in male gametocytes and RFP in female gameto-
cytes [75]. DNA quantification during exflagellation was also monitored by flow cytometry in
mutant P. berghei parasites. Development of ookinetes in wild type, mutants and sexual crosses
was observed in standard in vitro cultures maintained at 21°C. Mosquito transmission experi-
ments were done in 5–8 days old mosquitoes used for infected blood feeds at 21°C and moni-
tored for oocyst and sporozoite development. See S1 supplementary materials and methods
for details.
Determination of IC50 value of inhibitors in vitro
Inhibitors were used to perform in vitro drug susceptibility tests in standard cultures of syn-
chronized P. berghei and P. falciparum blood stages. For testing P. berghei inhibiton, inhibitors
were used at increasing concentrations to culture ring stage P. berghei for 24 hours and parasite
development to schizont stage was analyzed by flow cytometry after staining iRBCs with DNA-
specific dye Hoechst-33258. P. falciparum 3D7 strain was used for determining IC50 values of
inhibitors in in vitro cultures by measuring 3H-Hypoxanthine incorporation in the presence of
inhibitors in increasing concentrations. See S1 supplementary materials and methods for
details.
Ethics statement
All animal work was approved by the University of Glasgow’s Animal Welfare and Ethical Re-
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Committee, Australia. As a part of standard Australian Red Cross Blood Service practice, blood
was collected from healthy donors who were informed about this study and potential risks to
them and gave written consent when they donated blood.
Supporting Information
S1 Text. Fig A. A. Characterisation of the enriched reticulocyte population induced by Phenyl-
hydrazine-HCl (PHZ) by FACS analysis on day 5 post PHZ administration. Top panel shows
Ter119-FITC staining in RBCs which stains all erythroid cells. Bottom panels show
CD71-APC staining in RBCs which stains only reticulocytes (~35%) and the population of
CD71-high reticulocytes is almost 90% indicating that the majority of reticulocytes are very
young. B. Volcano plot showing the distribution of abundance of all ~4560 peaks detected
across both LC-MS and GC-MS platforms in Reticulocyte enriched Erythrocyte Population
(REP) as compared to wild type Erythrocyte Population (wtEP) in rodent blood. All significant
changes are represented above the broken horizontal line. Coloured dots indicate peaks which
are: Blue- significantly up-regulated, Red- significantly down-regulated, Yellow- significant but
little change, Brown- non-significant. n = 3 independent biological replicates (with four inter-
nal technical replicates each). Significance tested by Welch’s T-test (< 0.05). C. Fold change of
metabolite abundance in rodent Reticulocyte enriched Erythrocyte Population (REP) com-
pared to wild type Erythrocyte Population (wtEP). See S1 Table for metabolite names corre-
sponding to numbers. Fig B. A. Schematic representation of gene deletion strategy. B. Gel
electrophoresis of indicated PCR products to confirm integration of selection cassette, disrup-
tion of genes and clonality of mutant parasites (i) pepc (PBANKA_101790) (ii)mdh
(PBANKA_111770) (iii) oprt (PBANKA_111240) (iv) ompdc (PBANKA_050740). Fig C. A.
Competition growth assay using FACS analysis. Equal number of parasites (106) of wt popula-
tion expressing RFP under constitutive promoter eef1a (RMgm-86) and mutant population
made in a parent line expressing GFP under the same promoter (RMgm-7) were mixed and in-
jected into a mouse on day 0 and peripheral blood from the infected mouse was monitored
using FACS analyses for the proportion of RFP positive (wt) and GFP positive (mutant) para-
sites over the next 12 days. Infected cells were gated on forward-side scatter followed by
Hoechst 33258 staining and then on GFP and RFP staining as shown in the representative
FACS plots. Left panel on day 0 shows wt and mutant populations are in similar proportions
and right panel shows that over time (by days 6–12), wt population overgrows a slow growing
mutant. Infected blood was passaged into a new mouse when multiple infected cells started to
appear to allow for optimal growth. B. Time taken for asexual parasites to grow to mature
schizont stage. Coloured lines indicate non-linear fit of percentage of mature schizonts ob-
served in in vitro synchronous cultures of wt and mutant P. berghei parasites 22 hours post in-
vasion. Data representative of n = 3 independent biological replicates. C. Number of
merozoites per schizont grown in in vitro cultures as counted in giemsa stained smears. The
error is given as the SD of n 40 schizonts. Data representative of 3 independent biological
replicates. P-values: p<0.0005, unpaired two tailed t-test. D. FACS plots showing DNA
replication in male gametocytes observed by FACS analysis at the start of and 12 mins post
activation. DNA content was determined in Hoechst-33258-stained purified gametocytes
and flouroscence intensity is displayed on x-axis and cell counts on y- axis. Before activation
(0 min) males and females are shown in a gate with the same low DNA content (M+F). At
12 mins, prior to the formation of free male gametes, the DNA content of males increases as
shown in gate (M). E. Left panel: Intensity of Giemsa staining in wt and mutant P. berghei in-
fected reticulocytes. Intensity of the stain was found to be maximum in youngest reticulocytes.
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Smears were stained with 12% Giemsa stain for 10 mins after fixing and air drying with metha-
nol. Image data was processed in ImageJ. Gray values were calculated in minimum 100 pixels
across the whole host cell (parasites inside the cells were excluded) and staining intensities
(Gray value-1 normalised to mature erythrocytes) were plotted for n = 20 infected cells. P-val-
ues: p<0.005, p<0.0005, paired two tailed t-test. Right panel: representative pictures
showing P. berghei infected erythrocytes in smears stained with Giemsa where younger reticu-
locytes are stained darker. Fig D. A. Mosquito mid guts showing mature oocysts at day 14 post
infection in wt, pepc- andmdh- P.berghei infected mosquitoes. B. Mosquito salivary glands
showing sporozoites at day 21 post infection in wt, pepc- andmdh- P.berghei infected mosqui-
toes. C. Mosquito mid guts showing mature oocysts at day 14 post infection in wt, oprt- and
ompdc- P.berghei infected mosquitoes. D. Mosquito salivary glands showing sporozoites at day
21 post infection in wt, oprt- and ompdc- P.berghei infected mosquitoes. Fig E.Mosquito infec-
tivity as observed by counting mature fluorescent oocysts of in vivo crossed Pb270 x oprt- and
Pb270 x ompdc-mutant parasites compared to wt and self-fertilised Pb270 on day 14 post in-
fected blood feed in mosquito mid guts. n = 20 mosquitoes cumulative of two independent bio-
logical replicates. p<0.0005, unpaired two tailed t-test. Fig F. A. Schematic representation
of glutathione synthesis pathway in Plasmodium. ɣ-GCS (ɣ-glutamylcysteine synthetase), GS
(glutathionesSynthetase), GR (glutathione reductase) ɣ-GluCys (ɣ-L-glutamyl-L-cysteine),
GSSG (glutathione disulphide). B. Fold change of relative levels (peak intensities) of metabo-
lites of glutathione biosynthesis in rodent REP compared to wtEP. Dotted line indicates no
change and error bars indicate R.S.D. (Relative Standard Deviation) of peak intensities from re-
ticulocyte samples multiplied to the fold change values from n = 3 independent biological repli-
cates. It is expected that under these metabolomics extraction conditions the oxidised forms of
cystine and glutathione disulphide likely represent the sum of both oxidised and reduced forms
of cysteine and glutathione. C. P. berghei inhibition experiment with buthionine sulphoximine
(BSO) in vitro. Error bars indicate S.D. from n = 2 biological replicates. Fig G. Illustration of
ICM and Pyrimidine metabolism genes’ essentiality throughout P. berghei life cycle.
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S1 Table. Metabolites represented in Fig 1B showing fold change in abundance in uninfect-
ed Reticulocyte enriched Erythrocyte Population (REP)compared to wild type Erythrocyte
Population (wtEP) from rats.Metabolites are listed in order of decreasing abundance. Metab-
olites identified with authentic standards are highlighted bold, others are considered putative
identifications.
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S2 Table. List of primers used for generation of gene knockouts and confirmation.
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S3 Table. List of genes annotated with metabolic pathway information in P. falciparum on
PlasmoDB and their P. vivax and P. berghei orthologues.
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S1 Supplementary Materials and Methods. Details of materials and methods used for meta-
bolomics sample preparation, data acquisition and analysis, generation of gene deletion
mutants in P. berghei and phenotypic analysis.
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